The short isoforms of NSD2 and NSD3, which lack the catalytic SET domain, retain potent tumor-promoting capabilities by functioning as chromatin scaffolds, transcriptional adaptors, and protein interaction hubs (Figure 4 and Table 1). Here, NSD3 is linked to neoplasm.